Evaxion Reports Three-Year Data for Melanoma Vaccine EVX-01
Evaxion reports three-year data for melanoma vaccine EVX-01, a personalized neoantigen candidate; the disclosure headline omits survival endpoints and cohort details.
Section
Skin Cancer & Surgery
Melanoma and keratinocyte carcinoma, screening, Mohs and surgical outcomes.
Evaxion Brings Three-Year EVX-01 Melanoma Data to ESMO 2026
Evaxion will present three-year Phase 2 follow-up on its personalized neoantigen vaccine EVX-01 in advanced melanoma at ESMO 2026…
Moderna and Merck Present Phase 3 Melanoma Data on Personalized Cancer Vaccine
Moderna and Merck present Phase 3 melanoma findings for their personalized mRNA cancer vaccine; endpoints, effect sizes and filin…
Invion Reports 79% Disease Control in Phase 1 Skin Cancer Trial
Invion closed Phase 1 recruitment in non-melanoma skin cancer, reporting 79% disease control across 14 patients — an early signal…
AAFP Publishes Melanoma Diagnosis and Treatment Guidance
The AAFP has published a clinical review, "Melanoma: Diagnosis and Treatment," guiding family physicians on lesion assessment, bi…
Reflectance Confocal Microscopy Caught Melanomas Earlier, Retrospective Study Finds
A retrospective Frontiers analysis reports earlier melanoma detection with in vivo reflectance confocal microscopy, adding cellul…
Nebraska Clinics Offer New Therapy for Ocular Melanoma Liver Spread
Nebraska providers now offer a new treatment for rare uveal melanoma that spreads from the eye to the liver, giving regional pati…
Second-Opinion Pathology Reviews Before Derm Surgery: A JAAD Look
A JAAD study published online October 17, 2026 measures how second-opinion pathology reviews before dermatologic surgery change c…
Hungarian Hospital Reports Shorter Melanoma Delays via Digital Pathway
A Hungarian hospital reports shorter melanoma care delays with a digital patient pathway system, though effect sizes and staging…
Free Skin Cancer Screening Program Ends Its Run in Santa Barbara
A free skin cancer screening program is stopping in Santa Barbara, KSBY reports, ending no-cost early detection access for a high…